EUVIMEDEUVIMED entdecken
Crossref

Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk

Maria Sara Mauro iD, Davide Capodanno iD

Thrombosis and Haemostasis · 01.08.2025 · 125 (08) · 814-816

DOI: 10.1055/a-2544-6263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.08.2025. Verfasst von Maria Sara Mauro und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Cardiology, Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy.

ORCID-Profile: Maria Sara Mauro, Davide Capodanno

Zitieren

APA

Mauro, M. S., & Capodanno, D. (2025). Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk. Thrombosis and Haemostasis, 125(08), 814-816. https://doi.org/10.1055/a-2544-6263

Vancouver

Mauro MS, Capodanno D. Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk. Thrombosis and Haemostasis. 2025;125(08):814-816. doi:10.1055/a-2544-6263

BibTeX
@article{Mauro2025,
  author = {Mauro, Maria Sara and Capodanno, Davide},
  title = {Antiplatelet Therapy in Percutaneous Coronary Intervention Patients with Concurrent High Ischemic and Bleeding Risk},
  journal = {Thrombosis and Haemostasis},
  year = {2025},
  volume = {125},
  number = {08},
  pages = {814--816},
  doi = {10.1055/a-2544-6263}
}
Kostenlos starten →